{
    "2015-12-01": [
        "JNJ: Barclays ups to Overweight",
        "Roche Just Picked Up A Range Of Potential Billion Dollar Indications",
        "Barclays analyst Geoff Meacham assumed coverage with “overweight” rating of: Johnson & Johnson $JNJ, $115 target & Eli Lilly $LLY $95"
    ]
}